tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BIXT Stock Latest News

Bioxytran Inc Welcomes New Expert to Board, Modifies Stock Rights
Company AnnouncementsBioxytran Inc Welcomes New Expert to Board, Modifies Stock Rights
6h ago
8K
BIXT
Bioxytran Announces Preprint of Shingles Case Study Showing Clearance Using a Topical Galectin-3 Antagonist
PremiumPress Releases
Bioxytran Announces Preprint of Shingles Case Study Showing Clearance Using a Topical Galectin-3 Antagonist
1M ago
BIXT
Bioxytran Gets Broad Patent Coverage on 60+ Viruses
PremiumPress Releases
Bioxytran Gets Broad Patent Coverage on 60+ Viruses
6M ago
BIXT
Bioxytran Interview at the Emerging Growth Conference
PremiumPress Releases
Bioxytran Interview at the Emerging Growth Conference
7M ago
BIXT
Bioxytran Announces Broad Spectrum Antiviral Activity Highlighted in ProLectin-M
PremiumPress Releases
Bioxytran Announces Broad Spectrum Antiviral Activity Highlighted in ProLectin-M
7M ago
BIXT
Bioxytran Announces FDA Clearance of its IND Application for ProLectin-M in Clinical Trials
PremiumPress ReleasesBioxytran Announces FDA Clearance of its IND Application for ProLectin-M in Clinical Trials
8M ago
BIXT
Bioxytran Names Leslie Ajayi as Interim CMO and Head of the Medical Advisory Board
PremiumPress Releases
Bioxytran Names Leslie Ajayi as Interim CMO and Head of the Medical Advisory Board
9M ago
BIXT
Bioxytran Expands Institutional Investor Base with an additional $500,000 Equity Investment
PremiumPress Releases
Bioxytran Expands Institutional Investor Base with an additional $500,000 Equity Investment
10M ago
BIXT
Bioxytran Interview at the Emerging Growth Conference
PremiumPress Releases
Bioxytran Interview at the Emerging Growth Conference
1y ago
BIXT
Bioxytran Announces Positive Phase 2 Trial Results were Featured in “Vaccines” a Peer-Reviewed Journal
PremiumPress Releases
Bioxytran Announces Positive Phase 2 Trial Results were Featured in “Vaccines” a Peer-Reviewed Journal
1y ago
BIXT
Bioxytran to Appear on ClearThink IR’s Virtual Live Event
PremiumPress Releases
Bioxytran to Appear on ClearThink IR’s Virtual Live Event
1y ago
BIXT
Bioxytran Receives Approval to Initiate Trials with ProLectin-I
PremiumPress Releases
Bioxytran Receives Approval to Initiate Trials with ProLectin-I
1y ago
BIXT
Bioxytran Interview at the Emerging Growth Conference
PremiumPress ReleasesBioxytran Interview at the Emerging Growth Conference
1y ago
BIXT
Crystal Research Update Highlights 100% Responders Rate in Mild to Moderate COVID-19 Trial
PremiumPress Releases
Crystal Research Update Highlights 100% Responders Rate in Mild to Moderate COVID-19 Trial
1y ago
BIXT
Bioxytran Establishes Indian Subsidiary in Preparation of Commercialization
PremiumPress Releases
Bioxytran Establishes Indian Subsidiary in Preparation of Commercialization
1y ago
BIXT
Bioxytran Interview at the Emerging Growth Conference
PremiumPress Releases
Bioxytran Interview at the Emerging Growth Conference
1y ago
BIXT
Bioxytran Receives Approval to Optimize Dosage in COVID-19 Patients
PremiumPress Releases
Bioxytran Receives Approval to Optimize Dosage in COVID-19 Patients
1y ago
BIXT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >